Minerva Neurosciences Reports Q3 2026 Net Income of $100.7 Million
Third-quarter GAAP net income included a $109.6 million non-cash gain from changes in warrant-liability fair value. Excluding that gain and stock-based compensation, the company posted an adjusted net loss of $5.6 million.
Minerva Neurosciences reported third-quarter 2026 GAAP net income of $100.7 million, driven by a $109.6 million non-cash gain from changes in the fair value of its warrant liability. Excluding that gain and stock-based compensation, the company recorded an adjusted net loss of $5.6 million. Cash, c…